title: The influence of bexarotene, a selective agonist of the retinoid receptor X (RXR), and tazarotene, a selective agonist of the retinoid acid receptor (RAR), on bone metabolism in rats.
abstract: OBJECTIVE
  The purpose of this study was to investigate the influence of selective agonists of the retinoid receptor X (RXR) and the retinoid acid receptor (RAR) on bone metabolism in rats.
  
  
  METHODS
  Thirty six male Wistar rats were divided into three groups: receiving bexarotene, or tazarotene, or to control group. Serum biochemical markers of bone turnover (osteocalcin - OC, tartrate resistant acid phosphatase 5 - TRACP5b and osteoprotegerin - OPG) and mechanical properties of bones were analyzed.
  
  
  RESULTS
  There was a significant decrease in the femur index value in groups receiving tazarotene and bexarotene on Day 14 (8% and 20% respectively, p=0.0039). On Day 28, 14 days after discontinuation of tazarotene and bexarotene, the difference in femur indexes was still significant (4% for T1-6 and B1-6, p=0.0270). In the bexarotene group an increase in mean plasma osteocalcin level and mean plasma TRACP5b level was detected. In the tazarotene group the mean osteocalcin level remained unchanged and the mean plasma TRACP5b level decreased. An increased yield stress was detected in groups receiving retinoids comparing to controls after 14 days of tazarotene and bexarotene administration.
  
  
  CONCLUSIONS
  Although bexarotene and tazarotene administration caused decrease in the femur index, mechanisms responsible for that effect seem to be different. Our results suggest that bexaroten increases bone turnover. On the contrary, tazaroten seems to have inhibitory effect on bone turnover. A counter influence of selective RAR and RXR agonists on the bone turnover might be the reason for inconsistency in results from published research concerning the influence of retinoids on bone metabolism.
authors.affiliation: Department of Pharmacology, Wroclaw Medical University, Wrocław, Poland. Electronic address: beata.nowak@umed.wroc.pl.
authors.forename: Beata
authors.initials: B
authors.lastname: Nowak
authors.affiliation: Department of Pharmacology, Wroclaw Medical University, Wrocław, Poland.
authors.forename: Agnieszka
authors.initials: A
authors.lastname: Matuszewska
authors.affiliation: Division of Biomedical Engineering and Experimental Mechanics, Wroclaw University of Technology, Wrocław, Poland.
authors.forename: Jarosław
authors.initials: J
authors.lastname: Filipiak
authors.affiliation: Division of Biomedical Engineering and Experimental Mechanics, Wroclaw University of Technology, Wrocław, Poland.
authors.forename: Anna
authors.initials: A
authors.lastname: Nikodem
authors.affiliation: Department of Pharmacology, Wroclaw Medical University, Wrocław, Poland.
authors.forename: Anna
authors.initials: A
authors.lastname: Merwid-Ląd
authors.affiliation: Department of Pharmacology, Wroclaw Medical University, Wrocław, Poland.
authors.forename: Małgorzata
authors.initials: M
authors.lastname: Pieśniewska
authors.affiliation: Department of Pharmacology, Wroclaw Medical University, Wrocław, Poland.
authors.forename: Lidia
authors.initials: L
authors.lastname: Fereniec-Gołębiewska
authors.affiliation: Department of Pharmacology, Wroclaw Medical University, Wrocław, Poland.
authors.forename: Joanna
authors.initials: J
authors.lastname: Kwiatkowska
authors.affiliation: Department of Pharmacology, Wroclaw Medical University, Wrocław, Poland.
authors.forename: Adam
authors.initials: A
authors.lastname: Szeląg
mesh_terms: D000818:Animals; D000077610:Bexarotene; D015415:Biomarkers / Q000097:blood; D001835:Body Weight / Q000187:drug effects; D016723:Bone Remodeling / Q000187:drug effects; D001842:Bone and Bones / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D009539:Nicotinic Acids / Q000008:administration & dosage / Q000494:pharmacology*; D017208:Rats, Wistar; D018168:Receptors, Retinoic Acid / Q000819:agonists*; D047488:Retinoid X Receptors / Q000819:agonists*; D013764:Tetrahydronaphthalenes / Q000008:administration & dosage / Q000494:pharmacology*; D012176:Retinoids
chemical_list: D000077610:Bexarotene; D015415:Biomarkers; D009539:Nicotinic Acids; D018168:Receptors, Retinoic Acid; D047488:Retinoid X Receptors; D013764:Tetrahydronaphthalenes; C086827:tazarotene; D012176:Retinoids
keywords: Bone turnover; Retinoid acid receptor (RAR); Retinoid receptor X (RXR); Stress yield